Press releases | Finanzwire

Basculer en Français

10884	Companies
236863	Keywords
165747	Articles
127082	Press releases

Home
Press releases

REGULATED PRESS RELEASE

published on 10/21/2025 at 07:00, 10 months 5 days ago

Edenred reports higher growth in its activity in the third quarter of 2025 compared to the first half of the year
Edenred reports strong revenue growth in third-quarter 2025, with total revenue reaching €726 million, up 7.3% like-for-like. Operating revenue up 8.2%, driven by growth across all business lines and regions

Edenred Revenue Growth Business Lines Operating Revenue Q3 2025
REGULATED PRESS RELEASE

published on 10/21/2025 at 07:00, 10 months 5 days ago

2025 nine-month sales. €710m at constant exchange rates (+4.4%)
Interparfums reports €710m sales in first nine months of 2025, up 4.4% at constant exchange rates. Strong performance in flagship brands with Jimmy Choo fragrances driving growth

Sales Interparfums Growth Fragrances 2025
PRESS RELEASE

published on 10/21/2025 at 06:45, 10 months 5 days ago

HUBER+SUHNER achieves significantly higher order intake in the first nine months of 2025
HUBER+SUHNER achieves significantly higher order intake in the first nine months of 2025, with Communication segment leading the growth. Net sales reach prior-year level

Net Sales Order Intake HUBER+SUHNER Industry Segment Communication Segment
PRESS RELEASE

published on 10/21/2025 at 06:32, 10 months 5 days ago

Q3 2025: Solid Group revenue
Q3 2025: Solid Group revenue with Eurotunnel revenue up 3%. Eleclink revenue down 13%. Europorte revenue up 5%. CEO confirms EBITDA target

Group Revenue ElecLink EBITDA Target Eurotunnel Q3 2025
PRESS RELEASE

published on 10/21/2025 at 06:30, 10 months 5 days ago

Formycon’s FYB201/Ranivisio® sets innovative standard as Europe’s First Ranibizumab Biosimilar available in Pre-filled Syringe
Formycon's FYB201/Ranivisio® is Europe's First Ranibizumab Biosimilar available in Pre-filled Syringe, offering improved handling, accuracy, and convenience for applicants. Teva to commercialize across Europe

Europe Biosimilar Formycon Teva Ranivisio
PRESS RELEASE

published on 10/21/2025 at 05:28, 10 months 5 days ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
The Vanguard Group, Inc. discloses 3.57% stake in Spire Healthcare Group PLC. Purchase of 1p ordinary shares. Disclosure under Rule 8.3 of the Code

Rule 8.3 Vanguard Group Stake Disclosure 1p Ordinary Shares Spire Healthcare Group
PRESS RELEASE

published on 10/21/2025 at 05:26, 10 months 5 days ago

Form 8.3 - The Vanguard Group, Inc.: UNITE Group PLC/The
The Vanguard Group, Inc. submits Form 8.3 disclosing 4.97% stake in UNITE Group PLC/The. Details of ownership and dealings provided

Form 8.3 Vanguard Group Dealings Ownership Unite Group Plc
PRESS RELEASE

published on 10/21/2025 at 05:24, 10 months 5 days ago

Form 8.3 - The Vanguard Group, Inc.: NCC Group PLC
The Vanguard Group, Inc. discloses a 4.90% interest in NCC Group plc's 1p ordinary securities as of 17 October 2025

Securities Disclosure The Vanguard Group Interest NCC Group Plc
PRESS RELEASE

published on 10/21/2025 at 05:22, 10 months 5 days ago

Form 8.3 - The Vanguard Group, Inc.: Just Group PLC
The Vanguard Group, Inc. discloses a 5.37% ownership in Just Group plc. Purchase of 9,136 securities at 2.12 GBP per unit

The Vanguard Group Ownership Disclosure Financial Disclosure Securities Purchase Just Group Plc
PRESS RELEASE

published on 10/21/2025 at 05:20, 10 months 5 days ago

Form 8.3 - The Vanguard Group, Inc.: JTC PLC
The Vanguard Group, Inc. discloses 5.05% stake in JTC PLC as of 17 Oct 2025. Purchased 1,424 1p ordinary shares at 12.99 GBP. No other dealings disclosed

Vanguard Group Financial Disclosure Share Purchase Stake Disclosure JTC Plc

Accesswire

Published on 08/26/2026 at 15:25, 25 minutes ago

CF Energy Announces Financial Results for the Three-Month and Six-Month Periods Ended June 30, 2026
Published on 08/26/2026 at 15:00, 50 minutes ago

Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Published on 08/26/2026 at 15:00, 50 minutes ago

Arcus Announces Voting Results of the Annual General and Special Meeting
Published on 08/26/2026 at 14:30, 1 hour 20 minutes ago

Klondike Gold Reports Additional Montana Creek Royalty Gold Receipts, Announces Phase 2 2026 Drill Program and Provides Exploration Update
Published on 08/26/2026 at 14:30, 1 hour 20 minutes ago

NV Gold Announces Commencement of 2026 Drill Program at its Slumber Gold Project

View all ACCESSWIRE

EQS Group

Published on 08/26/2026 at 15:31, 18 minutes ago

Ground-breaking ceremony for the BVB Health Centre
Published on 08/26/2026 at 15:10, 40 minutes ago

Gastech 2026 Brings Global Energy Leaders to Bangkok as Asia Drives the Next Wave of Demand
Published on 08/26/2026 at 15:07, 42 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 08/26/2026 at 15:07, 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 08/26/2026 at 15:06, 44 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 08/25/2026 at 17:45, 22 hours 5 minutes ago

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 22 hours 5 minutes ago

Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
Published on 08/25/2026 at 08:30, 1 day 7 hours ago

Eiffage wins several contracts worth a total of €132 million in the healthcare sector
Published on 08/24/2026 at 18:00, 1 day 21 hours ago

Outstanding shares and voting rights statement at 31 July 2026
Published on 08/24/2026 at 17:59, 1 day 21 hours ago

Saint-Gobain strengthens its positioning in construction chemicals and light construction in Latin America

View all LES ECHOS COMFI WIRE